We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Regenerative Potential Is a Trait of Mature Tissues, Not an Innate Feature of Newly Born Cells

By LabMedica International staff writers
Posted on 25 Mar 2015
Diabetes researchers have found that the ability of insulin-producing beta cells to replicate and respond to elevated glucose concentrations is absent in very young animals and does not appear until after weaning.

Since the ability to regenerate tissue deteriorates with age, it was generally assumed that the younger the animal, the better it could compensate for damage tissues or organs. More...


Investigators at the Hebrew University of Jerusalem (Israel) examined the effect of young age on compensatory proliferation of pancreatic beta cells in vivo. Much to their surprise, they found that beta cells in suckling mice failed to enter the cell division cycle in response to a diabetes induced injury or increased glycolysis. However, when the mice were weaned to a high carbohydrate diet of pet chow—but not to a high fat diet that mimicked their mothers' milk—they developed the capacity for compensatory proliferation.

Weaning coincided with enhanced glucose-stimulated oxidative phosphorylation and insulin secretion from islets. Transcriptome analysis revealed that weaning increased the expression of genes involved in replication licensing, suggesting a mechanism for increased responsiveness to the mitogenic activity of high glucose. The investigators proposed in a paper published in the March 9, 2015, issue of the journal Developmental Cell that weaning triggered a discrete maturation step of beta cells that elevated both their mitogenic and secretory response to glucose. In light of these findings, the investigators will be searching for the exact molecular signal or pathway that triggered these events.

Senior author Dr. Yuval Dor, professor of developmental biology and cancer research at the Hebrew University of Jerusalem, said, “The data suggest that regenerative potential is a trait of mature tissues, which has to develop actively, similar to functional maturation, rather than an innate feature of newly born cells.”

Related Links:

Hebrew University of Jerusalem



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.